Tech Company Financing Transactions

Neuronetics Funding Round

Neuronetics closed a $35 million funding round on 9/30/2006. Investors included InterWest Partners, Investor Growth Capital and KBL Healthcare Ventures.

Transaction Overview

Company Name
Announced On
9/30/2006
Transaction Type
Venture Equity
Amount
$35,000,200
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3222 Phoenixville Pike
Malvern, PA 19355
USA
Email Address
Overview
Neuronetics is focused on successfully developing and commercializing noninvasive therapies to treat significant, chronic psychiatric and neurological disorders. We are committed to working collaboratively with the clinical community to improve care, at reasonable cost, for the many patients suffering from these disorders.
Profile
Neuronetics LinkedIn Company Profile
Social Media
Neuronetics Company Twitter Account
Company News
Neuronetics News
Facebook
Neuronetics on Facebook
YouTube
Neuronetics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Keith Sullivan
  Keith Sullivan LinkedIn Profile  Keith Sullivan Twitter Account  Keith Sullivan News  Keith Sullivan on Facebook
Chief Financial Officer
Peter Donato
  Peter Donato LinkedIn Profile  Peter Donato Twitter Account  Peter Donato News  Peter Donato on Facebook
Chief Financial Officer
Steve Furlong
  Steve Furlong LinkedIn Profile  Steve Furlong Twitter Account  Steve Furlong News  Steve Furlong on Facebook
VP - Bus. Development
Daniel Guthrie
  Daniel Guthrie LinkedIn Profile  Daniel Guthrie Twitter Account  Daniel Guthrie News  Daniel Guthrie on Facebook
VP - Bus. Development
Anthony Pui
  Anthony Pui LinkedIn Profile  Anthony Pui Twitter Account  Anthony Pui News  Anthony Pui on Facebook
VP - General Counsel
Andrew Macan
  Andrew Macan LinkedIn Profile  Andrew Macan Twitter Account  Andrew Macan News  Andrew Macan on Facebook
VP - Product Management
Greg Harper
  Greg Harper LinkedIn Profile  Greg Harper Twitter Account  Greg Harper News  Greg Harper on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2006: Virobay venture capital transaction
Next: 9/30/2006: Broncus Medical venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary